MOLECULAR BIOLOGY IN THE DIAGNOSIS AND PROGNOSIS OF HYPERTROPHIC CARDIOMYOPATHY

E. Elstein
Abstract:I want to discuss with you today the molecular biology of hypertrophic cardiomyopathy and how advances in this science have helped in the diagnosis and prognosis of this disease. To begin, I’m going to give you a brief review of some of the clinical features of this entity. Hypertrophic cardiomyopathy has a prevalence of three per 10,000 of population; it can present at any age, but most often manifests in the third to fourth decade, and there is an annual mortality rate of 3.5%.
What problem does this paper attempt to address?